

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 5.90785254 |
| 2 | nuclear pore organization (GO:0006999) | 5.32077270 |
| 3 | protein localization to kinetochore (GO:0034501) | 4.98678664 |
| 4 | * pre-miRNA processing (GO:0031054) | 4.94370167 |
| 5 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.86177261 |
| 6 | mitotic sister chromatid cohesion (GO:0007064) | 4.44634304 |
| 7 | heterochromatin organization (GO:0070828) | 4.21731482 |
| 8 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.19199291 |
| 9 | interkinetic nuclear migration (GO:0022027) | 4.14384467 |
| 10 | sister chromatid segregation (GO:0000819) | 4.09740705 |
| 11 | mitotic chromosome condensation (GO:0007076) | 4.08194469 |
| 12 | pore complex assembly (GO:0046931) | 4.07329710 |
| 13 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.97209644 |
| 14 | regulation of RNA export from nucleus (GO:0046831) | 3.95378288 |
| 15 | NLS-bearing protein import into nucleus (GO:0006607) | 3.95047483 |
| 16 | chromatin assembly (GO:0031497) | 3.92362350 |
| 17 | histone H4-K8 acetylation (GO:0043982) | 3.92291600 |
| 18 | histone H4-K5 acetylation (GO:0043981) | 3.92291600 |
| 19 | protein localization to chromosome, centromeric region (GO:0071459) | 3.90839322 |
| 20 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.90011175 |
| 21 | histone H4-K12 acetylation (GO:0043983) | 3.89162277 |
| 22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.87971445 |
| 23 | mitotic sister chromatid segregation (GO:0000070) | 3.87243115 |
| 24 | negative regulation of histone methylation (GO:0031061) | 3.83350430 |
| 25 | histone H4-K16 acetylation (GO:0043984) | 3.81250260 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.77692162 |
| 27 | histone H2A monoubiquitination (GO:0035518) | 3.75139211 |
| 28 | histone H3-K4 methylation (GO:0051568) | 3.73514441 |
| 29 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.67994008 |
| 30 | notochord development (GO:0030903) | 3.55212304 |
| 31 | establishment of protein localization to Golgi (GO:0072600) | 3.54823390 |
| 32 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.41852265 |
| 33 | histone H3-K4 trimethylation (GO:0080182) | 3.41404567 |
| 34 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.40643004 |
| 35 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.40603269 |
| 36 | regulation of sister chromatid cohesion (GO:0007063) | 3.39900584 |
| 37 | * mRNA stabilization (GO:0048255) | 3.39394422 |
| 38 | * RNA stabilization (GO:0043489) | 3.39394422 |
| 39 | regulation of pigment cell differentiation (GO:0050932) | 3.39179130 |
| 40 | protein targeting to Golgi (GO:0000042) | 3.38389996 |
| 41 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.38239650 |
| 42 | cellular response to ethanol (GO:0071361) | 3.36344161 |
| 43 | mitotic nuclear envelope disassembly (GO:0007077) | 3.35975038 |
| 44 | nucleus localization (GO:0051647) | 3.32906673 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.30107300 |
| 46 | DNA duplex unwinding (GO:0032508) | 3.29003552 |
| 47 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.28508462 |
| 48 | regulation of gene silencing by miRNA (GO:0060964) | 3.28508462 |
| 49 | regulation of gene silencing by RNA (GO:0060966) | 3.28508462 |
| 50 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.27415826 |
| 51 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.26688510 |
| 52 | DNA geometric change (GO:0032392) | 3.24542474 |
| 53 | peptidyl-lysine trimethylation (GO:0018023) | 3.24107326 |
| 54 | establishment of nucleus localization (GO:0040023) | 3.21982801 |
| 55 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.21777277 |
| 56 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.21777277 |
| 57 | nuclear envelope disassembly (GO:0051081) | 3.20840327 |
| 58 | membrane disassembly (GO:0030397) | 3.20840327 |
| 59 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.19825805 |
| 60 | histone H3-K9 demethylation (GO:0033169) | 3.19755313 |
| 61 | positive regulation of histone deacetylation (GO:0031065) | 3.19383687 |
| 62 | paraxial mesoderm development (GO:0048339) | 3.18464216 |
| 63 | neural tube formation (GO:0001841) | 3.17286673 |
| 64 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.16850838 |
| 65 | regulation of histone H3-K9 methylation (GO:0051570) | 3.16349917 |
| 66 | stress granule assembly (GO:0034063) | 3.15721575 |
| 67 | negative regulation of DNA repair (GO:0045738) | 3.15683425 |
| 68 | nerve growth factor signaling pathway (GO:0038180) | 3.15229734 |
| 69 | DNA unwinding involved in DNA replication (GO:0006268) | 3.14409579 |
| 70 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.13913097 |
| 71 | embryonic camera-type eye morphogenesis (GO:0048596) | 3.12691836 |
| 72 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.10118976 |
| 73 | somite rostral/caudal axis specification (GO:0032525) | 3.05857117 |
| 74 | cellular extravasation (GO:0045123) | 3.04239798 |
| 75 | histone lysine methylation (GO:0034968) | 3.02773446 |
| 76 | regulation of telomere maintenance (GO:0032204) | 3.02716508 |
| 77 | positive regulation of chromosome segregation (GO:0051984) | 2.95722171 |
| 78 | protein localization to chromosome (GO:0034502) | 2.95688763 |
| 79 | peptidyl-lysine dimethylation (GO:0018027) | 2.93986256 |
| 80 | histone mRNA catabolic process (GO:0071044) | 2.91615716 |
| 81 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.89802234 |
| 82 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.89802234 |
| 83 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.89802234 |
| 84 | peptidyl-threonine phosphorylation (GO:0018107) | 2.89011854 |
| 85 | negative regulation of epidermis development (GO:0045683) | 2.88865946 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 2.88763777 |
| 87 | positive regulation by symbiont of host defense response (GO:0052509) | 2.88763777 |
| 88 | modulation by symbiont of host defense response (GO:0052031) | 2.88763777 |
| 89 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.88763777 |
| 90 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.88763777 |
| 91 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.88763777 |
| 92 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.88450665 |
| 93 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.88394651 |
| 94 | trophectodermal cell differentiation (GO:0001829) | 2.87266949 |
| 95 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.86265379 |
| 96 | microglial cell activation (GO:0001774) | 2.85110791 |
| 97 | regulation of histone H3-K4 methylation (GO:0051569) | 2.84947017 |
| 98 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.84923613 |
| 99 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.84920318 |
| 100 | protein targeting to vacuole (GO:0006623) | 2.84915340 |
| 101 | protein targeting to lysosome (GO:0006622) | 2.84915340 |
| 102 | establishment of protein localization to vacuole (GO:0072666) | 2.84915340 |
| 103 | histone demethylation (GO:0016577) | 2.83468909 |
| 104 | histone H3-K9 modification (GO:0061647) | 2.81287807 |
| 105 | gene silencing by RNA (GO:0031047) | 2.80385656 |
| 106 | dosage compensation (GO:0007549) | 2.79985926 |
| 107 | primitive streak formation (GO:0090009) | 2.79823364 |
| 108 | maintenance of protein location in nucleus (GO:0051457) | 2.79576165 |
| 109 | macrophage activation involved in immune response (GO:0002281) | 2.79335644 |
| 110 | hippo signaling (GO:0035329) | 2.79095236 |
| 111 | corticosteroid receptor signaling pathway (GO:0031958) | 2.77668624 |
| 112 | polarized epithelial cell differentiation (GO:0030859) | 2.77436591 |
| 113 | histone methylation (GO:0016571) | 2.76016469 |
| 114 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.74856166 |
| 115 | body morphogenesis (GO:0010171) | 2.72747607 |
| 116 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.72465596 |
| 117 | peptidyl-threonine modification (GO:0018210) | 2.71613565 |
| 118 | histone H3-K9 methylation (GO:0051567) | 2.70649143 |
| 119 | chromosome condensation (GO:0030261) | 2.70366402 |
| 120 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.69900802 |
| 121 | centrosome localization (GO:0051642) | 2.69040498 |
| 122 | microtubule anchoring (GO:0034453) | 2.67946773 |
| 123 | gene silencing (GO:0016458) | 2.66848830 |
| 124 | neutrophil mediated immunity (GO:0002446) | 2.65777050 |
| 125 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.65608390 |
| 126 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.65321670 |
| 127 | nuclear envelope organization (GO:0006998) | 2.65244697 |
| 128 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.64347800 |
| 129 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.64103724 |
| 130 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.63475038 |
| 131 | regulation of mitotic spindle organization (GO:0060236) | 2.61848090 |
| 132 | regulation of hippo signaling (GO:0035330) | 2.61740607 |
| 133 | peptidyl-lysine methylation (GO:0018022) | 2.61439545 |
| 134 | phospholipid translocation (GO:0045332) | 2.61264057 |
| 135 | lipid translocation (GO:0034204) | 2.61264057 |
| 136 | regulation of establishment of cell polarity (GO:2000114) | 2.60841020 |
| 137 | DNA conformation change (GO:0071103) | 2.60499832 |
| 138 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.60399505 |
| 139 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.60399505 |
| 140 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.60399505 |
| 141 | head development (GO:0060322) | 2.60294190 |
| 142 | chromatin assembly or disassembly (GO:0006333) | 2.59016185 |
| 143 | I-kappaB phosphorylation (GO:0007252) | 2.58181232 |
| 144 | histone H3-K36 demethylation (GO:0070544) | 2.58016211 |
| 145 | histone lysine demethylation (GO:0070076) | 2.56933709 |
| 146 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.56641384 |
| 147 | protein K11-linked deubiquitination (GO:0035871) | 2.55568217 |
| 148 | dorsal/ventral axis specification (GO:0009950) | 2.55222816 |
| 149 | regulation of protein polyubiquitination (GO:1902914) | 2.55199419 |
| 150 | Golgi to endosome transport (GO:0006895) | 2.55133435 |
| 151 | regulation of spindle organization (GO:0090224) | 2.55042843 |
| 152 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.54449558 |
| 153 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.54329843 |
| 154 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.54225096 |
| 155 | detection of external biotic stimulus (GO:0098581) | 2.52899407 |
| 156 | regulation of gene silencing (GO:0060968) | 2.52108829 |
| 157 | * regulation of mRNA stability (GO:0043488) | 2.51389300 |
| 158 | gastrulation with mouth forming second (GO:0001702) | 2.50795046 |
| 159 | early endosome to late endosome transport (GO:0045022) | 2.50105402 |
| 160 | macrophage activation (GO:0042116) | 2.47688251 |
| 161 | positive regulation of macroautophagy (GO:0016239) | 2.46379216 |
| 162 | regulation of gamma-delta T cell activation (GO:0046643) | 2.46345754 |
| 163 | hepatocyte apoptotic process (GO:0097284) | 2.43643837 |
| 164 | genitalia morphogenesis (GO:0035112) | 2.42775004 |
| 165 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.41745867 |
| 166 | protein localization to cytoskeleton (GO:0044380) | 2.39807858 |
| 167 | protein dealkylation (GO:0008214) | 2.39083421 |
| 168 | protein demethylation (GO:0006482) | 2.39083421 |
| 169 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.38384600 |
| 170 | histone-serine phosphorylation (GO:0035404) | 2.38041130 |
| 171 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.36994330 |
| 172 | protein K48-linked deubiquitination (GO:0071108) | 2.35451016 |
| 173 | negative regulation of B cell proliferation (GO:0030889) | 2.34672881 |
| 174 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.32865284 |
| 175 | detection of other organism (GO:0098543) | 2.31750065 |
| 176 | myeloid leukocyte mediated immunity (GO:0002444) | 2.30632246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.23184334 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.17759006 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.34223524 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.34223524 |
| 5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.34223524 |
| 6 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.75792216 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.28921913 |
| 8 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 3.25987872 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.22774468 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.22056737 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.18800412 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.15117975 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.75785532 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.67684949 |
| 15 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.63633262 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.61213449 |
| 17 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 2.45925332 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.43183356 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.40427819 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.38596199 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.31273405 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.26399302 |
| 23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.24481556 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.21260738 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.18580129 |
| 26 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.17734077 |
| 27 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.17195921 |
| 28 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.16958501 |
| 29 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 2.14296256 |
| 30 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.12950968 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.08693556 |
| 32 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.08444243 |
| 33 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.05974780 |
| 34 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.02075683 |
| 35 | * HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.01608158 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99363599 |
| 37 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.96466587 |
| 38 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.93613696 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84610469 |
| 40 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.83097006 |
| 41 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.82290825 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81741792 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77138644 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.76767506 |
| 45 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.73435782 |
| 46 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.72766841 |
| 47 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.72432565 |
| 48 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.72195429 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70851233 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70717389 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67600705 |
| 52 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.67137963 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64670879 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64555400 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.64238387 |
| 56 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.62971810 |
| 57 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61029874 |
| 58 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.59686682 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.59024994 |
| 60 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.58510103 |
| 61 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57732961 |
| 62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57421179 |
| 63 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.56840067 |
| 64 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.55130652 |
| 65 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.52687019 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.52495261 |
| 67 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51726737 |
| 68 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.51509140 |
| 69 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.51416536 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51416536 |
| 71 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.50434551 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50066086 |
| 73 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49806558 |
| 74 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.49289726 |
| 75 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.49281232 |
| 76 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.48806776 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.47951915 |
| 78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47873100 |
| 79 | TP53_16413492_ChIP-PET_HCT116_Human | 1.47615925 |
| 80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46423597 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.46376518 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42353387 |
| 83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41069481 |
| 84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.40719168 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40684780 |
| 86 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.39304196 |
| 87 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38168710 |
| 88 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.36647649 |
| 89 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.36244322 |
| 90 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35328844 |
| 91 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.34756034 |
| 92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34060998 |
| 93 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.32464816 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30996341 |
| 95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30834977 |
| 96 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.29552763 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29017095 |
| 98 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27557190 |
| 99 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.26977381 |
| 100 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26920782 |
| 101 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26446303 |
| 102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26237673 |
| 103 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.26073379 |
| 104 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25694550 |
| 105 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.25457376 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24802782 |
| 107 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.24645205 |
| 108 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.23668653 |
| 109 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23219167 |
| 110 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21990118 |
| 111 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.21695635 |
| 112 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21679911 |
| 113 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21645226 |
| 114 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21484084 |
| 115 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20855541 |
| 116 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20631576 |
| 117 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20493403 |
| 118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20407226 |
| 119 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20076790 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19358634 |
| 121 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19063634 |
| 122 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.18974441 |
| 123 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18228750 |
| 124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18087180 |
| 125 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17620772 |
| 126 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17620772 |
| 127 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15479059 |
| 128 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15094367 |
| 129 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14720924 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14616628 |
| 131 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13380765 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13232598 |
| 133 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12862574 |
| 134 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12689068 |
| 135 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12509653 |
| 136 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12229718 |
| 137 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11328769 |
| 138 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10913947 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09370773 |
| 140 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09370773 |
| 141 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09302738 |
| 142 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09109140 |
| 143 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08727402 |
| 144 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08658640 |
| 145 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07518648 |
| 146 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07500112 |
| 147 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.06214607 |
| 148 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05562569 |
| 149 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05546012 |
| 150 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05289331 |
| 151 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05243909 |
| 152 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04746953 |
| 153 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04691533 |
| 154 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04558278 |
| 155 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03986353 |
| 156 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03319981 |
| 157 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00239666 |
| 158 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.98771176 |
| 159 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.95326687 |
| 160 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95281444 |
| 161 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.94381814 |
| 162 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93841595 |
| 163 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.92937570 |
| 164 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91431697 |
| 165 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90616609 |
| 166 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90157352 |
| 167 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89685901 |
| 168 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.87937418 |
| 169 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86329414 |
| 170 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.84721789 |
| 171 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.84487889 |
| 172 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.83457288 |
| 173 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.83371743 |
| 174 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83222056 |
| 175 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.82789066 |
| 176 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82387901 |
| 177 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.81845094 |
| 178 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.81324894 |
| 179 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81180581 |
| 180 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.80746702 |
| 181 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.80104907 |
| 182 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79617196 |
| 183 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.77232863 |
| 184 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76528179 |
| 185 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.75703917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002009_preneoplasia | 4.14188283 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 3.42987320 |
| 3 | MP0003121_genomic_imprinting | 3.42432838 |
| 4 | MP0003890_abnormal_embryonic-extraembry | 3.27175433 |
| 5 | MP0005409_darkened_coat_color | 3.09255513 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.86734188 |
| 7 | MP0003123_paternal_imprinting | 2.83513391 |
| 8 | MP0003122_maternal_imprinting | 2.71757754 |
| 9 | MP0003787_abnormal_imprinting | 2.62084155 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.54830726 |
| 11 | MP0005076_abnormal_cell_differentiation | 2.42578388 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.34093426 |
| 13 | MP0003724_increased_susceptibility_to | 2.23665025 |
| 14 | MP0005380_embryogenesis_phenotype | 2.22518176 |
| 15 | MP0001672_abnormal_embryogenesis/_devel | 2.22518176 |
| 16 | MP0005174_abnormal_tail_pigmentation | 2.16559698 |
| 17 | MP0003111_abnormal_nucleus_morphology | 2.15269332 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.12106009 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.11453550 |
| 20 | MP0002084_abnormal_developmental_patter | 2.10632628 |
| 21 | MP0002088_abnormal_embryonic_growth/wei | 2.06377969 |
| 22 | MP0003303_peritoneal_inflammation | 2.05977284 |
| 23 | MP0003984_embryonic_growth_retardation | 2.05868188 |
| 24 | * MP0003077_abnormal_cell_cycle | 2.00663713 |
| 25 | MP0010094_abnormal_chromosome_stability | 2.00318625 |
| 26 | * MP0002085_abnormal_embryonic_tissue | 1.92241258 |
| 27 | MP0004197_abnormal_fetal_growth/weight/ | 1.91740726 |
| 28 | MP0009703_decreased_birth_body | 1.84677912 |
| 29 | MP0000537_abnormal_urethra_morphology | 1.83982866 |
| 30 | * MP0000350_abnormal_cell_proliferation | 1.83127351 |
| 31 | MP0003690_abnormal_glial_cell | 1.81748728 |
| 32 | * MP0002086_abnormal_extraembryonic_tissu | 1.79787581 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.79680008 |
| 34 | * MP0001730_embryonic_growth_arrest | 1.77465173 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.75265065 |
| 36 | MP0010030_abnormal_orbit_morphology | 1.75169434 |
| 37 | MP0001849_ear_inflammation | 1.73122760 |
| 38 | MP0005499_abnormal_olfactory_system | 1.71352275 |
| 39 | MP0005394_taste/olfaction_phenotype | 1.71352275 |
| 40 | MP0001293_anophthalmia | 1.70952735 |
| 41 | MP0003119_abnormal_digestive_system | 1.69243309 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.64060161 |
| 43 | MP0000569_abnormal_digit_pigmentation | 1.63977564 |
| 44 | * MP0003935_abnormal_craniofacial_develop | 1.63965035 |
| 45 | * MP0003937_abnormal_limbs/digits/tail_de | 1.60979951 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.59536168 |
| 47 | MP0003221_abnormal_cardiomyocyte_apopto | 1.58976972 |
| 48 | * MP0001697_abnormal_embryo_size | 1.58890948 |
| 49 | MP0009053_abnormal_anal_canal | 1.58515156 |
| 50 | * MP0010678_abnormal_skin_adnexa | 1.58437545 |
| 51 | MP0002092_abnormal_eye_morphology | 1.54869213 |
| 52 | MP0001188_hyperpigmentation | 1.54218011 |
| 53 | MP0003283_abnormal_digestive_organ | 1.54094256 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.52017224 |
| 55 | MP0003828_pulmonary_edema | 1.49436928 |
| 56 | MP0004381_abnormal_hair_follicle | 1.49053755 |
| 57 | MP0003091_abnormal_cell_migration | 1.48701880 |
| 58 | MP0009672_abnormal_birth_weight | 1.48504369 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.47612243 |
| 60 | MP0005248_abnormal_Harderian_gland | 1.47356100 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.45222724 |
| 62 | MP0000432_abnormal_head_morphology | 1.42274255 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.40712732 |
| 64 | MP0008877_abnormal_DNA_methylation | 1.40669306 |
| 65 | MP0002932_abnormal_joint_morphology | 1.38912392 |
| 66 | MP0005310_abnormal_salivary_gland | 1.38525752 |
| 67 | * MP0000428_abnormal_craniofacial_morphol | 1.38367916 |
| 68 | MP0003755_abnormal_palate_morphology | 1.36005654 |
| 69 | MP0000733_abnormal_muscle_development | 1.35236179 |
| 70 | MP0002653_abnormal_ependyma_morphology | 1.34465566 |
| 71 | MP0005187_abnormal_penis_morphology | 1.27723767 |
| 72 | MP0003632_abnormal_nervous_system | 1.26580054 |
| 73 | MP0002233_abnormal_nose_morphology | 1.26337555 |
| 74 | * MP0002925_abnormal_cardiovascular_devel | 1.25783545 |
| 75 | MP0010307_abnormal_tumor_latency | 1.25310941 |
| 76 | * MP0002080_prenatal_lethality | 1.24932662 |
| 77 | MP0002006_tumorigenesis | 1.23919047 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.23549896 |
| 79 | MP0003693_abnormal_embryo_hatching | 1.22080910 |
| 80 | MP0002697_abnormal_eye_size | 1.21940933 |
| 81 | MP0002254_reproductive_system_inflammat | 1.21885070 |
| 82 | MP0004883_abnormal_blood_vessel | 1.20640409 |
| 83 | MP0003861_abnormal_nervous_system | 1.19699637 |
| 84 | MP0003385_abnormal_body_wall | 1.19452243 |
| 85 | MP0002909_abnormal_adrenal_gland | 1.19281747 |
| 86 | MP0003195_calcinosis | 1.18025186 |
| 87 | MP0010234_abnormal_vibrissa_follicle | 1.15011461 |
| 88 | MP0003938_abnormal_ear_development | 1.13127687 |
| 89 | MP0001851_eye_inflammation | 1.12937452 |
| 90 | MP0003868_abnormal_feces_composition | 1.09348321 |
| 91 | MP0003315_abnormal_perineum_morphology | 1.08916647 |
| 92 | MP0009115_abnormal_fat_cell | 1.07360377 |
| 93 | MP0002116_abnormal_craniofacial_bone | 1.07142656 |
| 94 | MP0000678_abnormal_parathyroid_gland | 1.03148369 |
| 95 | MP0000516_abnormal_urinary_system | 1.02038243 |
| 96 | MP0005367_renal/urinary_system_phenotyp | 1.02038243 |
| 97 | MP0001286_abnormal_eye_development | 1.01976997 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 1.00116070 |
| 99 | MP0003300_gastrointestinal_ulcer | 0.99880242 |
| 100 | * MP0002114_abnormal_axial_skeleton | 0.99501554 |
| 101 | MP0002396_abnormal_hematopoietic_system | 0.98579216 |
| 102 | MP0008789_abnormal_olfactory_epithelium | 0.98475586 |
| 103 | MP0000427_abnormal_hair_cycle | 0.98270417 |
| 104 | MP0003045_fibrosis | 0.98197888 |
| 105 | MP0008932_abnormal_embryonic_tissue | 0.98031085 |
| 106 | * MP0000383_abnormal_hair_follicle | 0.97239492 |
| 107 | MP0000647_abnormal_sebaceous_gland | 0.95727244 |
| 108 | MP0002111_abnormal_tail_morphology | 0.95225476 |
| 109 | MP0003763_abnormal_thymus_physiology | 0.94195626 |
| 110 | MP0004858_abnormal_nervous_system | 0.94138587 |
| 111 | MP0003115_abnormal_respiratory_system | 0.92469153 |
| 112 | MP0000371_diluted_coat_color | 0.91927637 |
| 113 | MP0003942_abnormal_urinary_system | 0.91249441 |
| 114 | MP0005451_abnormal_body_composition | 0.91105878 |
| 115 | MP0000778_abnormal_nervous_system | 0.90552953 |
| 116 | MP0001915_intracranial_hemorrhage | 0.90360888 |
| 117 | MP0001800_abnormal_humoral_immune | 0.90204870 |
| 118 | MP0002938_white_spotting | 0.89821749 |
| 119 | MP0008770_decreased_survivor_rate | 0.89286427 |
| 120 | MP0002168_other_aberrant_phenotype | 0.89167533 |
| 121 | MP0003191_abnormal_cellular_cholesterol | 0.89163781 |
| 122 | MP0000462_abnormal_digestive_system | 0.88578652 |
| 123 | MP0000049_abnormal_middle_ear | 0.88449498 |
| 124 | * MP0000266_abnormal_heart_morphology | 0.85606977 |
| 125 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84109126 |
| 126 | MP0002638_abnormal_pupillary_reflex | 0.83814666 |
| 127 | MP0009780_abnormal_chondrocyte_physiolo | 0.83742085 |
| 128 | * MP0002081_perinatal_lethality | 0.83353066 |
| 129 | MP0002249_abnormal_larynx_morphology | 0.83341979 |
| 130 | MP0004130_abnormal_muscle_cell | 0.83136767 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.82665995 |
| 132 | MP0005391_vision/eye_phenotype | 0.82636245 |
| 133 | MP0000762_abnormal_tongue_morphology | 0.80694476 |
| 134 | MP0010368_abnormal_lymphatic_system | 0.80375792 |
| 135 | MP0003252_abnormal_bile_duct | 0.79659355 |
| 136 | MP0010630_abnormal_cardiac_muscle | 0.78068958 |
| 137 | MP0000465_gastrointestinal_hemorrhage | 0.78016649 |
| 138 | MP0001177_atelectasis | 0.76837838 |
| 139 | MP0003631_nervous_system_phenotype | 0.75572780 |
| 140 | MP0003566_abnormal_cell_adhesion | 0.74805769 |
| 141 | MP0002928_abnormal_bile_duct | 0.73050582 |
| 142 | MP0005666_abnormal_adipose_tissue | 0.72413556 |
| 143 | * MP0000313_abnormal_cell_death | 0.71924990 |
| 144 | * MP0008057_abnormal_DNA_replication | 0.71877896 |
| 145 | MP0005623_abnormal_meninges_morphology | 0.71872235 |
| 146 | MP0003941_abnormal_skin_development | 0.71806592 |
| 147 | MP0009250_abnormal_appendicular_skeleto | 0.71022210 |
| 148 | MP0002419_abnormal_innate_immunity | 0.68602604 |
| 149 | MP0001186_pigmentation_phenotype | 0.67542654 |
| 150 | MP0003656_abnormal_erythrocyte_physiolo | 0.66658333 |
| 151 | MP0004484_altered_response_of | 0.66617283 |
| 152 | MP0000955_abnormal_spinal_cord | 0.65518213 |
| 153 | MP0003633_abnormal_nervous_system | 0.63748286 |
| 154 | MP0004510_myositis | 0.63306606 |
| 155 | * MP0002398_abnormal_bone_marrow | 0.63255917 |
| 156 | * MP0000377_abnormal_hair_follicle | 0.62761621 |
| 157 | MP0002332_abnormal_exercise_endurance | 0.62131838 |
| 158 | MP0004134_abnormal_chest_morphology | 0.61833280 |
| 159 | MP0003453_abnormal_keratinocyte_physiol | 0.60991763 |
| 160 | MP0002452_abnormal_antigen_presenting | 0.58476311 |
| 161 | * MP0000703_abnormal_thymus_morphology | 0.57142049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Papillary thyroid carcinoma (HP:0002895) | 4.45100876 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 4.01939268 |
| 3 | Hepatoblastoma (HP:0002884) | 3.81732636 |
| 4 | Ependymoma (HP:0002888) | 3.77991979 |
| 5 | Bilateral microphthalmos (HP:0007633) | 3.75942607 |
| 6 | Volvulus (HP:0002580) | 3.47911546 |
| 7 | Astrocytoma (HP:0009592) | 3.18160813 |
| 8 | Abnormality of the astrocytes (HP:0100707) | 3.18160813 |
| 9 | Acute myeloid leukemia (HP:0004808) | 2.99381104 |
| 10 | Difficulty running (HP:0009046) | 2.98833412 |
| 11 | Rib fusion (HP:0000902) | 2.88626868 |
| 12 | Short 4th metacarpal (HP:0010044) | 2.87448410 |
| 13 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.87448410 |
| 14 | Macroorchidism (HP:0000053) | 2.86259651 |
| 15 | Abnormality of the lower motor neuron (HP:0002366) | 2.85006778 |
| 16 | Eczematoid dermatitis (HP:0000976) | 2.81064860 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 2.77367262 |
| 18 | Renal duplication (HP:0000075) | 2.73823059 |
| 19 | * Thyroid carcinoma (HP:0002890) | 2.71097968 |
| 20 | Curly hair (HP:0002212) | 2.68463889 |
| 21 | Abnormality of the fingertips (HP:0001211) | 2.67542822 |
| 22 | T lymphocytopenia (HP:0005403) | 2.65512826 |
| 23 | * Neoplasm of striated muscle (HP:0009728) | 2.65394371 |
| 24 | Pseudobulbar signs (HP:0002200) | 2.64266555 |
| 25 | Neoplasm of the oral cavity (HP:0100649) | 2.64177215 |
| 26 | Increased nuchal translucency (HP:0010880) | 2.57068852 |
| 27 | Heterotopia (HP:0002282) | 2.56477392 |
| 28 | Glioma (HP:0009733) | 2.56112396 |
| 29 | Abnormality of chromosome segregation (HP:0002916) | 2.54644087 |
| 30 | Low anterior hairline (HP:0000294) | 2.53871698 |
| 31 | Neonatal hypoglycemia (HP:0001998) | 2.52333776 |
| 32 | Shawl scrotum (HP:0000049) | 2.50406466 |
| 33 | Supernumerary ribs (HP:0005815) | 2.47363920 |
| 34 | Large earlobe (HP:0009748) | 2.42271212 |
| 35 | Fair hair (HP:0002286) | 2.33620539 |
| 36 | Abnormal hair whorl (HP:0010721) | 2.30068903 |
| 37 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.30000658 |
| 38 | Broad thumb (HP:0011304) | 2.28642916 |
| 39 | Absent frontal sinuses (HP:0002688) | 2.28453790 |
| 40 | Hip dysplasia (HP:0001385) | 2.27831256 |
| 41 | Vertebral arch anomaly (HP:0008438) | 2.27502419 |
| 42 | Aqueductal stenosis (HP:0002410) | 2.25969073 |
| 43 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.25616004 |
| 44 | Skin tags (HP:0010609) | 2.25348501 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.24945589 |
| 46 | Abnormality of the 4th metacarpal (HP:0010012) | 2.23540317 |
| 47 | Cystic hygroma (HP:0000476) | 2.21056427 |
| 48 | Bifid tongue (HP:0010297) | 2.20213929 |
| 49 | Abnormality of T cell number (HP:0011839) | 2.18345779 |
| 50 | Abnormality of the labia minora (HP:0012880) | 2.15934673 |
| 51 | * Rhabdomyosarcoma (HP:0002859) | 2.14102179 |
| 52 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.13488957 |
| 53 | Chromsome breakage (HP:0040012) | 2.12636426 |
| 54 | Long eyelashes (HP:0000527) | 2.10315197 |
| 55 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.09640123 |
| 56 | Hypopigmentation of the fundus (HP:0007894) | 2.08752510 |
| 57 | Impulsivity (HP:0100710) | 2.08132062 |
| 58 | Neoplasm of the heart (HP:0100544) | 2.07535848 |
| 59 | Lip pit (HP:0100267) | 2.07286151 |
| 60 | Thickened calvaria (HP:0002684) | 2.06770513 |
| 61 | Widely spaced teeth (HP:0000687) | 2.06428232 |
| 62 | Preauricular skin tag (HP:0000384) | 2.05989698 |
| 63 | Generalized hypopigmentation of hair (HP:0011358) | 2.05665194 |
| 64 | Embryonal renal neoplasm (HP:0011794) | 2.05081230 |
| 65 | Thick eyebrow (HP:0000574) | 2.04953511 |
| 66 | Gastrointestinal carcinoma (HP:0002672) | 2.04461351 |
| 67 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.04461351 |
| 68 | Hypoplastic labia majora (HP:0000059) | 2.04013669 |
| 69 | Genetic anticipation (HP:0003743) | 2.03981883 |
| 70 | Gingivitis (HP:0000230) | 2.03557147 |
| 71 | Conjunctival telangiectasia (HP:0000524) | 2.03482780 |
| 72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.01443158 |
| 73 | Drooling (HP:0002307) | 2.01134004 |
| 74 | Protruding tongue (HP:0010808) | 2.00836284 |
| 75 | Tapered finger (HP:0001182) | 2.00816700 |
| 76 | Excessive salivation (HP:0003781) | 1.99556666 |
| 77 | Uterine leiomyosarcoma (HP:0002891) | 1.99130816 |
| 78 | Leiomyosarcoma (HP:0100243) | 1.99130816 |
| 79 | Abnormality of incisor morphology (HP:0011063) | 1.99121310 |
| 80 | Prominent nose (HP:0000448) | 1.98920125 |
| 81 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97811585 |
| 82 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.93183070 |
| 83 | Short humerus (HP:0005792) | 1.92282799 |
| 84 | Skin pits (HP:0100276) | 1.91941232 |
| 85 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.91790738 |
| 86 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.91790738 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90888899 |
| 88 | Multiple enchondromatosis (HP:0005701) | 1.90739896 |
| 89 | Spontaneous hematomas (HP:0007420) | 1.90650330 |
| 90 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.90186186 |
| 91 | Deviation of the thumb (HP:0009603) | 1.89652585 |
| 92 | Truncal obesity (HP:0001956) | 1.89355944 |
| 93 | Proximal placement of thumb (HP:0009623) | 1.88886031 |
| 94 | Obsessive-compulsive behavior (HP:0000722) | 1.88724217 |
| 95 | Inappropriate behavior (HP:0000719) | 1.88569346 |
| 96 | Midline defect of the nose (HP:0004122) | 1.87965937 |
| 97 | Facial hemangioma (HP:0000329) | 1.87621673 |
| 98 | Shallow orbits (HP:0000586) | 1.87381184 |
| 99 | Broad palm (HP:0001169) | 1.86573635 |
| 100 | Subacute progressive viral hepatitis (HP:0006572) | 1.86204734 |
| 101 | Intestinal fistula (HP:0100819) | 1.86045311 |
| 102 | Atresia of the external auditory canal (HP:0000413) | 1.86010251 |
| 103 | Sandal gap (HP:0001852) | 1.85401651 |
| 104 | Trigonocephaly (HP:0000243) | 1.84668854 |
| 105 | Periodontitis (HP:0000704) | 1.84642794 |
| 106 | Germ cell neoplasia (HP:0100728) | 1.83879563 |
| 107 | Abnormality of the nasal septum (HP:0000419) | 1.83813438 |
| 108 | Abnormality of the salivary glands (HP:0010286) | 1.83618365 |
| 109 | Cutis marmorata (HP:0000965) | 1.83444341 |
| 110 | Hyperventilation (HP:0002883) | 1.83126578 |
| 111 | Anal stenosis (HP:0002025) | 1.82811899 |
| 112 | Biliary tract neoplasm (HP:0100574) | 1.82773217 |
| 113 | Abnormality of the ischium (HP:0003174) | 1.81137858 |
| 114 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80865668 |
| 115 | Optic neuritis (HP:0100653) | 1.80608490 |
| 116 | Retrobulbar optic neuritis (HP:0100654) | 1.80608490 |
| 117 | Broad phalanges of the hand (HP:0009768) | 1.80561686 |
| 118 | Abnormality of the labia majora (HP:0012881) | 1.79039669 |
| 119 | Bladder carcinoma (HP:0002862) | 1.78630778 |
| 120 | Bladder neoplasm (HP:0009725) | 1.78630778 |
| 121 | Menstrual irregularities (HP:0000858) | 1.78578120 |
| 122 | Spinal cord lesions (HP:0100561) | 1.78066658 |
| 123 | Syringomyelia (HP:0003396) | 1.78066658 |
| 124 | Long clavicles (HP:0000890) | 1.77989331 |
| 125 | Disinhibition (HP:0000734) | 1.75870375 |
| 126 | Subaortic stenosis (HP:0001682) | 1.75633768 |
| 127 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.75633768 |
| 128 | Narrow palate (HP:0000189) | 1.75570906 |
| 129 | Short 5th finger (HP:0009237) | 1.75305389 |
| 130 | Cubitus valgus (HP:0002967) | 1.74809871 |
| 131 | Insidious onset (HP:0003587) | 1.74015339 |
| 132 | Termporal pattern (HP:0011008) | 1.74015339 |
| 133 | Cortical dysplasia (HP:0002539) | 1.73620225 |
| 134 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.73542186 |
| 135 | Hypoplasia of the maxilla (HP:0000327) | 1.73511403 |
| 136 | Periauricular skin pits (HP:0100277) | 1.72523686 |
| 137 | Preauricular pit (HP:0004467) | 1.72523686 |
| 138 | Skull defect (HP:0001362) | 1.72175378 |
| 139 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.71949835 |
| 140 | Abnormal pancreas size (HP:0012094) | 1.71139176 |
| 141 | Overgrowth (HP:0001548) | 1.69945420 |
| 142 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.69135766 |
| 143 | Hyperacusis (HP:0010780) | 1.68878515 |
| 144 | Abnormal lung lobation (HP:0002101) | 1.68819219 |
| 145 | Broad finger (HP:0001500) | 1.68692704 |
| 146 | Gingival bleeding (HP:0000225) | 1.68304763 |
| 147 | Deep philtrum (HP:0002002) | 1.68024156 |
| 148 | Neoplasm of the adrenal cortex (HP:0100641) | 1.67232133 |
| 149 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.66889720 |
| 150 | Abnormality of the corticospinal tract (HP:0002492) | 1.66027112 |
| 151 | Ulnar bowing (HP:0003031) | 1.65415176 |
| 152 | Abnormality of the pubic bones (HP:0003172) | 1.65232948 |
| 153 | Viral hepatitis (HP:0006562) | 1.65032048 |
| 154 | Lymphangioma (HP:0100764) | 1.64976451 |
| 155 | Urethral obstruction (HP:0000796) | 1.64796722 |
| 156 | Scanning speech (HP:0002168) | 1.64525834 |
| 157 | Abnormality of the diencephalon (HP:0010662) | 1.64425268 |
| 158 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.63271134 |
| 159 | Ectopic kidney (HP:0000086) | 1.62094094 |
| 160 | Coarse hair (HP:0002208) | 1.61303673 |
| 161 | Vertebral fusion (HP:0002948) | 1.61173862 |
| 162 | Hemivertebrae (HP:0002937) | 1.61151525 |
| 163 | Asymmetry of the thorax (HP:0001555) | 1.61085231 |
| 164 | Cafe-au-lait spot (HP:0000957) | 1.60934628 |
| 165 | Resting tremor (HP:0002322) | 1.60823082 |
| 166 | Abnormality of the axillary hair (HP:0100134) | 1.60756593 |
| 167 | Abnormality of secondary sexual hair (HP:0009888) | 1.60756593 |
| 168 | Abnormal number of incisors (HP:0011064) | 1.60658422 |
| 169 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.59947489 |
| 170 | Blue irides (HP:0000635) | 1.59716717 |
| 171 | Thyroiditis (HP:0100646) | 1.59639183 |
| 172 | Thickened helices (HP:0000391) | 1.59550233 |
| 173 | Smooth philtrum (HP:0000319) | 1.59421460 |
| 174 | Mask-like facies (HP:0000298) | 1.58278100 |
| 175 | Renovascular hypertension (HP:0100817) | 1.57648806 |
| 176 | Prominent occiput (HP:0000269) | 1.57513847 |
| 177 | Abnormality of the musculature of the hand (HP:0001421) | 1.57204753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.61270264 |
| 2 | LATS1 | 3.68183676 |
| 3 | MAP3K9 | 3.14479140 |
| 4 | SGK2 | 2.76302083 |
| 5 | CDC7 | 2.69429093 |
| 6 | MAP3K10 | 2.56342636 |
| 7 | FRK | 2.53267941 |
| 8 | TTK | 2.50419625 |
| 9 | EEF2K | 2.10518412 |
| 10 | RIPK1 | 2.07236065 |
| 11 | TYRO3 | 2.07205232 |
| 12 | STK10 | 2.02013292 |
| 13 | TNIK | 1.98604163 |
| 14 | CASK | 1.82327996 |
| 15 | NLK | 1.80312439 |
| 16 | BRD4 | 1.74763661 |
| 17 | YES1 | 1.74458018 |
| 18 | MARK1 | 1.67791714 |
| 19 | NEK2 | 1.67715833 |
| 20 | SGK223 | 1.63988178 |
| 21 | SGK494 | 1.63988178 |
| 22 | LATS2 | 1.62579344 |
| 23 | PDGFRA | 1.61276057 |
| 24 | ERN1 | 1.59178836 |
| 25 | CAMK1G | 1.58674316 |
| 26 | CAMK1D | 1.55686998 |
| 27 | STK3 | 1.55684605 |
| 28 | MTOR | 1.54297018 |
| 29 | WNK1 | 1.52580296 |
| 30 | TAF1 | 1.51319343 |
| 31 | GRK6 | 1.51158753 |
| 32 | MAP3K2 | 1.46199587 |
| 33 | MAP3K14 | 1.45806878 |
| 34 | ALK | 1.44558210 |
| 35 | BLK | 1.43259313 |
| 36 | ACVR1B | 1.42899944 |
| 37 | PKN2 | 1.37439979 |
| 38 | FGR | 1.35498795 |
| 39 | CHEK1 | 1.30194538 |
| 40 | KSR1 | 1.28309087 |
| 41 | CHEK2 | 1.27200380 |
| 42 | TRIB3 | 1.25029327 |
| 43 | PIK3CG | 1.22236149 |
| 44 | RIPK4 | 1.22183901 |
| 45 | CDK7 | 1.19954596 |
| 46 | ICK | 1.18293808 |
| 47 | IRAK1 | 1.16348907 |
| 48 | GRK5 | 1.15527403 |
| 49 | IRAK2 | 1.13246330 |
| 50 | HIPK2 | 1.11381310 |
| 51 | FGFR3 | 1.10851716 |
| 52 | CDK4 | 1.06063333 |
| 53 | CSF1R | 1.03991836 |
| 54 | ATM | 1.03842481 |
| 55 | MAP3K13 | 1.01158062 |
| 56 | TAOK3 | 1.00730289 |
| 57 | MAP3K4 | 0.98770484 |
| 58 | RPS6KB2 | 0.96978344 |
| 59 | PDGFRB | 0.96971837 |
| 60 | MKNK2 | 0.96440420 |
| 61 | PRKD3 | 0.95533765 |
| 62 | BMPR1B | 0.94400684 |
| 63 | MARK2 | 0.94189681 |
| 64 | NEK9 | 0.94054712 |
| 65 | JAK1 | 0.92918605 |
| 66 | CDK6 | 0.92910137 |
| 67 | KSR2 | 0.92790796 |
| 68 | MELK | 0.92338488 |
| 69 | STK38L | 0.92017204 |
| 70 | CDK2 | 0.90832572 |
| 71 | ERBB3 | 0.89309620 |
| 72 | MAPK7 | 0.88875981 |
| 73 | PLK1 | 0.87579354 |
| 74 | SGK1 | 0.87310165 |
| 75 | PIK3CA | 0.83477627 |
| 76 | ATR | 0.82815439 |
| 77 | RPS6KB1 | 0.82139197 |
| 78 | FGFR2 | 0.81137338 |
| 79 | TGFBR2 | 0.79859681 |
| 80 | MAP3K7 | 0.79021336 |
| 81 | PASK | 0.78238215 |
| 82 | ERBB2 | 0.77648035 |
| 83 | PTK6 | 0.77245997 |
| 84 | CDK9 | 0.76910544 |
| 85 | PNCK | 0.76424885 |
| 86 | STK24 | 0.75974034 |
| 87 | CSNK1D | 0.75285106 |
| 88 | DMPK | 0.74184404 |
| 89 | CSNK1E | 0.74162140 |
| 90 | MKNK1 | 0.73845930 |
| 91 | JAK2 | 0.72484562 |
| 92 | TEC | 0.71428866 |
| 93 | STK11 | 0.71140136 |
| 94 | CDK1 | 0.71133278 |
| 95 | NTRK3 | 0.70577787 |
| 96 | CDK3 | 0.70020937 |
| 97 | NUAK1 | 0.69615674 |
| 98 | SIK1 | 0.69125811 |
| 99 | TRPM7 | 0.68939246 |
| 100 | TYK2 | 0.67836524 |
| 101 | BTK | 0.67723776 |
| 102 | PAK4 | 0.67003025 |
| 103 | CAMKK2 | 0.65922041 |
| 104 | CSNK1A1L | 0.65663118 |
| 105 | MAP3K8 | 0.65623385 |
| 106 | HCK | 0.65039192 |
| 107 | PTK2 | 0.64169269 |
| 108 | EPHA3 | 0.64062192 |
| 109 | IRAK4 | 0.63520720 |
| 110 | MAPK14 | 0.63229530 |
| 111 | MAP2K4 | 0.63152948 |
| 112 | MAP3K6 | 0.62810396 |
| 113 | IKBKE | 0.62646515 |
| 114 | FGFR4 | 0.62356628 |
| 115 | MAP2K3 | 0.61067101 |
| 116 | MAPK10 | 0.59966591 |
| 117 | MAPK13 | 0.58718533 |
| 118 | GSK3B | 0.58346681 |
| 119 | BMX | 0.56692806 |
| 120 | GRK1 | 0.56150478 |
| 121 | PAK3 | 0.55970354 |
| 122 | EPHA2 | 0.55908279 |
| 123 | STK38 | 0.55505433 |
| 124 | WNK3 | 0.55260114 |
| 125 | TTN | 0.54824081 |
| 126 | CHUK | 0.54720016 |
| 127 | NTRK1 | 0.54218351 |
| 128 | NEK6 | 0.53610100 |
| 129 | PRKAA1 | 0.53407434 |
| 130 | RET | 0.53274547 |
| 131 | MET | 0.53092503 |
| 132 | INSRR | 0.52251902 |
| 133 | AKT3 | 0.51736171 |
| 134 | AURKB | 0.51666106 |
| 135 | DYRK1A | 0.51420340 |
| 136 | PRKD2 | 0.50626577 |
| 137 | CDC42BPA | 0.50484790 |
| 138 | STK4 | 0.50205620 |
| 139 | MAPK1 | 0.50176223 |
| 140 | FGFR1 | 0.50069558 |
| 141 | PRKDC | 0.49448479 |
| 142 | EGFR | 0.49280424 |
| 143 | FES | 0.48627056 |
| 144 | CAMK4 | 0.48502478 |
| 145 | AKT2 | 0.48079008 |
| 146 | PAK2 | 0.47880899 |
| 147 | AKT1 | 0.46913861 |
| 148 | JAK3 | 0.46693821 |
| 149 | SYK | 0.46412082 |
| 150 | CSNK1G1 | 0.45108158 |
| 151 | PRKAA2 | 0.45076792 |
| 152 | PTK2B | 0.44829784 |
| 153 | ERBB4 | 0.44198365 |
| 154 | SIK2 | 0.43429570 |
| 155 | TAOK1 | 0.43328213 |
| 156 | NTRK2 | 0.42948190 |
| 157 | STK39 | 0.42852231 |
| 158 | FER | 0.41337603 |
| 159 | PDK1 | 0.38764028 |
| 160 | SGK3 | 0.38327738 |
| 161 | CSK | 0.37419204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysine degradation_Homo sapiens_hsa00310 | 2.68059345 |
| 2 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 2.27042178 |
| 3 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.08059700 |
| 4 | Cell cycle_Homo sapiens_hsa04110 | 2.00995912 |
| 5 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.94552830 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 1.91276307 |
| 7 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.82690213 |
| 8 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.80782274 |
| 9 | Adherens junction_Homo sapiens_hsa04520 | 1.74373593 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.69762555 |
| 11 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.57888493 |
| 12 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.57632324 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54424593 |
| 14 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.54302184 |
| 15 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.53518415 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48342940 |
| 17 | Thyroid cancer_Homo sapiens_hsa05216 | 1.39183702 |
| 18 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.38826346 |
| 19 | Endometrial cancer_Homo sapiens_hsa05213 | 1.34951872 |
| 20 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.34104262 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33859543 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.31740016 |
| 23 | Colorectal cancer_Homo sapiens_hsa05210 | 1.29814588 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.29288372 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.28553571 |
| 26 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26129174 |
| 27 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.23769213 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.23727336 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21734579 |
| 30 | RNA degradation_Homo sapiens_hsa03018 | 1.21105824 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20267656 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19356881 |
| 33 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.18156936 |
| 34 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.15164920 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15104489 |
| 36 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.13693749 |
| 37 | Prostate cancer_Homo sapiens_hsa05215 | 1.13559552 |
| 38 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.11214404 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11022429 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10760649 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.10409796 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.08154015 |
| 43 | Insulin resistance_Homo sapiens_hsa04931 | 1.06123430 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05250857 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04540557 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04489526 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03927904 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.03872675 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03776188 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.02915318 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02689969 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02396993 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.01676866 |
| 54 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.00649080 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.99311504 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97784258 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97361107 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97346800 |
| 59 | Tight junction_Homo sapiens_hsa04530 | 0.96660232 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.96588748 |
| 61 | Pathways in cancer_Homo sapiens_hsa05200 | 0.96334581 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94368738 |
| 63 | Spliceosome_Homo sapiens_hsa03040 | 0.93588976 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93518867 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.93508276 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.93438956 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93030036 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89875198 |
| 69 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88336531 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88177045 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.87627968 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87610552 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86011916 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84884945 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84394125 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83678927 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83418735 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.81436837 |
| 79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81351513 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81147521 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80974841 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80897352 |
| 83 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80885980 |
| 84 | Influenza A_Homo sapiens_hsa05164 | 0.80758454 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79619509 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78510479 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.78477927 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.77825591 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77672067 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.77210257 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76778132 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74946830 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73767128 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73651499 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73441887 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.72966262 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71962967 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71382828 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71024927 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70399569 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69875899 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68075079 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68018166 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66644386 |
| 105 | Mismatch repair_Homo sapiens_hsa03430 | 0.66556297 |
| 106 | Gap junction_Homo sapiens_hsa04540 | 0.65684239 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65428464 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64881328 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63994853 |
| 110 | Legionellosis_Homo sapiens_hsa05134 | 0.62770066 |
| 111 | Axon guidance_Homo sapiens_hsa04360 | 0.62623143 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62213238 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62014500 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61908240 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61347880 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60482081 |
| 117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58038897 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56846669 |
| 119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.55481033 |
| 120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54825967 |
| 121 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54816849 |
| 122 | Melanogenesis_Homo sapiens_hsa04916 | 0.54166111 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53696777 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.53080863 |
| 125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.51451271 |
| 126 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49098612 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48118992 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44970834 |
| 129 | Homologous recombination_Homo sapiens_hsa03440 | 0.44249991 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42590829 |
| 131 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41826978 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41589278 |
| 133 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.40447503 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40263511 |
| 135 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40021372 |
| 136 | Long-term depression_Homo sapiens_hsa04730 | 0.39034026 |
| 137 | Hepatitis B_Homo sapiens_hsa05161 | 0.38975901 |

